Jeff Henderson MDPhD🌻 on Twitter

“1/6 With omicron bearing down and a critical mass of new data, FDA revised its emergency use authorization for COVID-19 convalescent plasma (CCP) to allow outpatient, as well as inpatient, use in patients with immunosuppressive disease or treatment. Why? https://t.co/gI3yN9DZf8”

Read the full article here

Related Articles